Relative to its peers, OGEN does not have very much institutional sponsorship. The 13.79% of shares outstanding held by institutional investors is among the least of any stock in the Biotechnology industry.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
JACOBS LEVY EQUITY MANAGEMENT, I... Bought 27.6 Thousand shares of Oragenics Inc
CITADEL ADVISORS LLC Bought 14.6 Thousand shares of Oragenics Inc
THE VANGUARD GROUP, INC. Bought 4.7 Thousand shares of Oragenics Inc